• About
  • Terms of Use
  • Privacy & Policy
  • Cookie policy
  • “press@ustechtimes.com”.
USTechTimes, Magazine & Review WordPress Theme 2017
  • Home
  • topics
    • All
    • AgTech
    • AI
    • Analytics
    • AR/VR
    • Biotech
    • Blockchain
    • Cars / autonomous vehicles
    • Clean tech / environment
    • Cloud infrastructure
    • Cryptocurrency
    • Data services
    • Developer tools
    • E-commerce
    • Education
    • Energy tech
    • Enterprise
    • Entertainment & sports
    • Security
    PartsTech, a Boston-based car component startup, bags $35 million

    PartsTech, a Boston-based car component startup, bags $35 million

    Gradiant raises $225 million in Series D, enters the unicorn club

    Gradiant raises $225 million in Series D, enters the unicorn club

    Ohmium, a green hydrogen startup closes $250 million Series C

    Ohmium, a green hydrogen startup closes $250 million Series C

    Vedanta Biosciences, a clinical-stage company, secured $106.5 million

    Vedanta Biosciences, a clinical-stage company, secured $106.5 million

    Trending Tags

      • Advertising
      • AgTech
      • AI
      • Analytics
      • AR/VR
      • Biotech
      • Blockchain
      • Cars / autonomous vehicles
      • Clean tech / environment
      • Cloud infrastructure
      • Consumer health & fitness
      • Consumer products
      • Cryptocurrency
      • Data services
      • Developer tools
      • Distributed workforce
      • E-commerce
      • Education
      • Energy tech
      • Enterprise
      • Entertainment & sports
      • Fashion
      • Fintech
      • Food and beverage
      • Games
      • Gaming/eSports
      • Govtech
      • Hardware
      • Health & hospital services
      • Health IT
      • Human capital
      • Impact
      • Insurance
      • IoT
      • Local commerce
      • Lodging/hospitality
      • Logistics
      • Manufacturing
      • Marketing automation
      • Marketplaces
      • Material science
      • Media/content
      • Medical devices
      • Messaging
      • Network infrastructure
      • Parenting/families
      • Payments
      • Pharmaceuticals
      • Real estate/proptech
      • Retail
      • Robotics
      • SaaS
      • Sales and CRM
      • Security
      • SMB software
      • Social commerce
      • Social mobile
      • Space
      • Gaming/eSports
      • Travel
      • Games
    • Interview
    • Venture Capital
    No Result
    View All Result
    • Home
    • topics
      • All
      • AgTech
      • AI
      • Analytics
      • AR/VR
      • Biotech
      • Blockchain
      • Cars / autonomous vehicles
      • Clean tech / environment
      • Cloud infrastructure
      • Cryptocurrency
      • Data services
      • Developer tools
      • E-commerce
      • Education
      • Energy tech
      • Enterprise
      • Entertainment & sports
      • Security
      PartsTech, a Boston-based car component startup, bags $35 million

      PartsTech, a Boston-based car component startup, bags $35 million

      Gradiant raises $225 million in Series D, enters the unicorn club

      Gradiant raises $225 million in Series D, enters the unicorn club

      Ohmium, a green hydrogen startup closes $250 million Series C

      Ohmium, a green hydrogen startup closes $250 million Series C

      Vedanta Biosciences, a clinical-stage company, secured $106.5 million

      Vedanta Biosciences, a clinical-stage company, secured $106.5 million

      Trending Tags

        • Advertising
        • AgTech
        • AI
        • Analytics
        • AR/VR
        • Biotech
        • Blockchain
        • Cars / autonomous vehicles
        • Clean tech / environment
        • Cloud infrastructure
        • Consumer health & fitness
        • Consumer products
        • Cryptocurrency
        • Data services
        • Developer tools
        • Distributed workforce
        • E-commerce
        • Education
        • Energy tech
        • Enterprise
        • Entertainment & sports
        • Fashion
        • Fintech
        • Food and beverage
        • Games
        • Gaming/eSports
        • Govtech
        • Hardware
        • Health & hospital services
        • Health IT
        • Human capital
        • Impact
        • Insurance
        • IoT
        • Local commerce
        • Lodging/hospitality
        • Logistics
        • Manufacturing
        • Marketing automation
        • Marketplaces
        • Material science
        • Media/content
        • Medical devices
        • Messaging
        • Network infrastructure
        • Parenting/families
        • Payments
        • Pharmaceuticals
        • Real estate/proptech
        • Retail
        • Robotics
        • SaaS
        • Sales and CRM
        • Security
        • SMB software
        • Social commerce
        • Social mobile
        • Space
        • Gaming/eSports
        • Travel
        • Games
      • Interview
      • Venture Capital
      No Result
      View All Result
      USTechTimes - Leading Startup and Technology News in the United States
      No Result
      View All Result
      Home topics Biotech

      Vedanta Biosciences, a clinical-stage company, secured $106.5 million

      Vedanta Biosciences is creating a potentially new class of oral treatments based on established bacterial consortia.

      USTechTimes Editor by USTechTimes Editor
      April 26, 2023
      Vedanta Biosciences, a clinical-stage company, secured $106.5 million
      Share on FacebookShare on Twitter

      Vedanta Biosciences, a Massachusetts-based clinical-stage company, has raised $106.5 million in funding. Along with current investors Bill & Melinda Gates Foundation, Skyviews Life Science, Reimagined Ventures, Fiscus Ventures, PEAK6, and Atlantic Neptune, the investor syndicate was co-led by new investors AXA IM Alts and The AMR Action Fund.

      Along with existing investors such as co-founder PureTech Health, Revelation Partners, QUAD Investment Management, Seventure Partners, Hambro Perks, and Pfizer Inc., new investors K2 HealthVentures, Korea Investment Partners, Korea Investment & Securities Asia Ltd., and Korea Investment & Securities US, Inc. also took part.

      Congratulations to new portfolio company @VedantaBio on a $106.5M financing to support their novel pipeline of rationally-defined microbiome therapeutics, including the Phase 3 development for their lead program. Read more: https://t.co/xwWlyXQl6V pic.twitter.com/d1V9ktaUGA

      — K2 HealthVentures (@K2HVenture) April 25, 2023

      The microbiome-focused business plans to utilize the cash, among other things, for the pivotal-stage development of its lead candidate, VE303, to treat ulcerative colitis and prevent recurrent Clostridioides difficile infection (CDI).

      Vedanta Biosciences is creating a potentially new class of oral treatments based on established bacterial consortia. Defined bacterial consortia are made from cell banks and are products with standardized composition, eliminating the need to rely on donor feces with variable composition.

      “We are grateful to have the support of our new and existing investors, who share our vision of pioneering microbiome therapeutics based on defined bacterial consortia to transform the lives of patients with serious diseases,” said Bernat Olle, Ph.D., Co-founder and Chief Executive Officer of Vedanta Biosciences.

      Vedanta Biosciences is leading the development of a potential new category of oral therapies

      Proceeds will primarily fund a pivotal Phase 3 research of VE303 in recurrent CDI and a Phase 2 proof-of-concept study of VE202 in ulcerative colitis. The Journal of the American Medical Association (JAMA) recently released good Phase 2 data for VE303 from Vedanta in patients with recurrent CDI.

      In the United States, C. difficile is responsible for up to 165,000 recurrent infections and up to 45,000 yearly deaths, causing about 500,000 infections yearly.

      The Biomedical Advanced Research and Development Authority (BARDA) granted a $23.8 million contract option in response to the Phase 2 study’s encouraging findings, initially disclosed in October 2021, to support a Phase 3 clinical trial of VE303.

      Under contract number 75A5012C00177, with a contract value of up to $81.9 million, the Department of Health and Human Services Administration for Strategic Preparedness and Response (BARDA) provided federal funding for this project in part.

      “Our Phase 2 clinical data and this new funding enable us to continue advancing the microbiome field beyond products made from fecal donations and towards pharmaceutical-grade, defined medicines,” said Bernat Olle.

      Related Posts

      • Software and payment company SpotOn nets $300 million for technology development

        San Francisco, California-based software and payments company SpotOn has raised $300 million in a Series…

      • Nuclear Fusion company TAE technologies bags $250 million in its latest funding round

        The promise of clean energy from nuclear fusion continues to fire up investors. TAE Technologies…

      • Rebuy, omnichannel personalization platform bags $17 million

        Rebuy, a Salt Lake City, UT-based omnichannel personalization platform for online retailers, has raised $17…

      Tags: BiotechfundingHealth TechnologyHealthtechinvestmentUS startup
      USTechTimes Editor

      USTechTimes Editor

      USTechTimes.com is an independent new media site that focuses on the latest technology and digital news in the United States and around the world. The site focuses on new startup launching, startup funding, and development in the startup space.

      Related Posts

      KSGC2023
      Events

      Apply Now for K-Startup Grand Challenge 2023 to join the most prominent global acceleration program in South Korea before May 18th

      May 9, 2023
      PreAct Technologies Closes 2nd Round of $20 Million Series B
      Uncategorized

      PreAct Technologies Closes 2nd Round of $20 Million Series B

      April 26, 2023
      Green tech firm Locus Fermentation Solutions bags $117 million
      Clean tech / environment

      Green tech firm Locus Fermentation Solutions bags $117 million

      April 10, 2023
      Boston Metal secures $120 million in a round led by ArcelorMittal
      Uncategorized

      Boston Metal secures $120 million in a round led by ArcelorMittal

      January 30, 2023
      Metagenomi bags an extra $100 million before closing its Series B
      Biotech

      Metagenomi bags an extra $100 million before closing its Series B

      January 11, 2023
      Aspen Neuroscience sign $40 million debt deal with Silicon Valley Bank
      Biotech

      Aspen Neuroscience sign $40 million debt deal with Silicon Valley Bank

      December 30, 2022
      No Result
      View All Result

      FREE NEWSLETTER

       

      PRODUCTS

      USTechTimes – Leading Startup and Technology News in the United States

      USTechTimes.com is an independent new media site that focuses on the latest technology and digital news in the United States and around the world. The site focuses on new startup launching, startup funding, and development in the startup space.

      More from our network


      • ktd

      • atd

      • itd

      • ktt

      • kgd

      • kpp

      • ktp

      • kpoppost

      • ustechtimes

      Categories

      • Accelerator
      • Animation
      • Apple
      • Applications
      • Artificial Intelligence
      • Advertising
      • AgTech
      • AI
      • Analytics
      • AR/VR
      • About
      • Terms of Use
      • Privacy & Policy
      • Cookie policy
      • “press@ustechtimes.com”.

      © 2023 ustechtimes.com

      No Result
      View All Result
      • Home
      • topics
        • Advertising
        • AgTech
        • AI
        • Analytics
        • AR/VR
        • Biotech
        • Blockchain
        • Cars / autonomous vehicles
        • Clean tech / environment
        • Cloud infrastructure
        • Consumer health & fitness
        • Consumer products
        • Cryptocurrency
        • Data services
        • Developer tools
        • Distributed workforce
        • E-commerce
        • Education
        • Energy tech
        • Enterprise
        • Entertainment & sports
        • Fashion
        • Fintech
        • Food and beverage
        • Games
        • Gaming/eSports
        • Govtech
        • Hardware
        • Health & hospital services
        • Health IT
        • Human capital
        • Impact
        • Insurance
        • IoT
        • Local commerce
        • Lodging/hospitality
        • Logistics
        • Manufacturing
        • Marketing automation
        • Marketplaces
        • Material science
        • Media/content
        • Medical devices
        • Messaging
        • Network infrastructure
        • Parenting/families
        • Payments
        • Pharmaceuticals
        • Real estate/proptech
        • Retail
        • Robotics
        • SaaS
        • Sales and CRM
        • Security
        • SMB software
        • Social commerce
        • Social mobile
        • Space
        • Gaming/eSports
        • Travel
        • Games
      • Interview
      • Venture Capital

      © 2023 ustechtimes.com